glp-1 and trump President announced the popular weight loss drugs would soon be more accessible to millions of Americans at a cost of only $50 per month Trump administration makes deal to
Description
When appetite returns and medication effects fade, blood sugar levels can rebound rapidly
Personalized dietary advice could help patients set realistic expectations about their outcomes, as GLP-1 medications are not cure-alls, and significant lifestyle changes may be beneficial
Many plans also require: Prior authorization Documentation of medical necessity Records of previous weight-management efforts Ongoing monitoring by a healthcare provider Some plans may require step therapy, meaning lower-cost treatments must be tried before Wegovy is approved
The definitive impact of tirzepatide on cardiovascular disease will be addressed in the ongoing SURPASS-COVT study (ClinicalTrials.gov number, NCT04255433), which compares tirzepatide with dulaglutide in patients with T2DM and ASCVD
It also follows the approval of Bristol Myers Squibb and 2seventy Bios Abecma in third line multiple myeloma
